The Pharmacy Times® COVID-19 Resource Center is a comprehensive resource for clinical news and expert insights on COVID-19, an infectious disease caused by the SARS-CoV-2 virus, including vaccine information and treatments for the disease.
August 28th 2025
COVID-19 vaccination significantly reduces the risk of asthma and other airway inflammatory diseases, offering vital protection against respiratory complications.
August 27th 2025
The FDA's approvals follow new COVID-19 guidance announced by the commissioner of the agency in May 2025, focusing future approvals on older adults.
August 26th 2025
Rhinovirus infection, which causes the common cold, could offer infected children more respiratory pathway protection from SARS-CoV-2 infection.
August 20th 2025
The development of multisystem inflammatory syndrome in children infected with SARS-CoV-2 was associated with more marked shifts in metabolic parameters, leading to increased cardiovascular disease risk.
August 11th 2025
Individuals who have survived childhood cancer had a higher risk of developing a severe COVID-19 infection, while exhibiting a lower risk of contracting the virus.
Study: Excessive Alcohol Consumption During the COVID-19 Pandemic
November 5th 2020The greater effect on population-wide alcohol use could be tied to the effects of the COVID-19 pandemic, including widespread social disruption and isolation, limited social support and access to medical care, and negative domestic and global economic impacts.
Read More
Study: Reduction in Essential Outings was More Pronounced in Dense Regions During COVID-19 Pandemic
November 4th 2020Study shows large reductions in visits to essential stores during the pandemic, such as pharmacies, but found essentially no reduction in non-essential visits to parks and other outdoor spots.
Read More
How Federal and State Law May Affect Vaccine Administration During the COVID-19 Pandemic
November 4th 2020Pharmacy Times® interviewed Ned Milenkovich, PharmD, JD, principal and co-chair of the Health Care Law practice group at Much Shelist, on how federal and state law may affect vaccine administration in accordance with recent HHS declarations.
Watch
Despite FDA Approval of Remdesivir, Experts Say Public Health Strategies Are Still Essential
November 2nd 2020Study suggests COVID-19 cases and deaths in the United States in the fall and winter will far exceed those of spring 2020 unless there is effective implementation of nationally coordinated efforts and preventive strategies.
Read More
Pharmacy Focus Episode 11: Dealing With a Pandemic in Pharmacy School
October 30th 2020The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.
Listen
Supporting Economic Growth Among Community, Retail Pharmacies During the COVID-19 Pandemic
October 29th 2020Pharmacy Times® interviewed Maryland Secretary of Commerce Kelly M. Schulz on how growth in the health care and biotech industry can support economic revitalization during and following the COVID-19 pandemic among community and retail pharmacies.
Watch
Study: Coronavirus Vaccines Stir Doubts Among People Worldwide
October 26th 2020The investigators found that 72% of participants would likely take the vaccine based on data collected from the previously validated COVID-SCORE survey of a sample of more than 13,400 individuals from 19 countries that were hard-hit by the virus.
Read More
Dual Threats of COVID-19, Influenza Could Have Devastating Effects on Adults with Chronic Conditions
October 23rd 2020The relationship between the flu and heart disease is of particular concern during the pandemic, as severe COVID-19 outcomes have also been associated with exacerbated cardiovascular conditions.
Read More
2 Commerce Drive
Cranbury, NJ 08512